(CHINOXALIN-2-YL-1,4-DIOXYD)-(AETHEN-1'-YL)-KETONE, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE VERBINDUNGENENTHALTENDE ARZNEIMITTEL SOWIE BEIFUTTERMITTEL, FUTTERMITTELKONZENTRATE UND FUTTERMITTEL

The invention relates to novel quinoxaline-2-yl ethenyl ketones, their preparation and compositions containing them. The novel quinoxaline-2-yl ethenyl ketones of the general formula I (I) wherein R1 represents an aryl group or a heterocyclic group comprising one or more nitrogen and/or oxygen and/or sulfur atoms wherein both the aryl and heterocyclic groups are optionally substituted by one or more identical or different substituents, R2 stands for a hydrogen atom or a C1-4 alkyl group, are prepared by reacting an acetylquinoxaline derivative of the general formula II (II) wherein R2 is as stated above, with an aldehyde of the general formula III R1-CHO (III) wherein R1 is as stated above. The novel compounds of the general formula I possess valuable antibacterial effect and promote the growth of animals. Thus, the novel compounds can be incorporated in animal feeds.